Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A1 | P53985 | 18/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 10/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.57 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Azd3965 SCHEMBL2875156 | 0.85 | SLC16A1 (0.48) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| Azd3965 SCHEMBL5093552 | 0.85 | SLC16A1 (0.48) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL5099894 | 0.84 | SLC16A1 (0.49) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL3827907 | 0.83 | SLC16A1 (0.80) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL3827911 | 0.83 | SLC16A1 (0.80) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL3827006 | 0.82 | SLC16A1 (0.83) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL26200805 | 0.80 | SLC16A1 (0.85) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL3871847 | 0.76 | SLC16A1 (0.84) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL3871850 | 0.76 | SLC16A1 (0.84) | SLC16A1CYP2C9CYP3A4SLC16A3 | |
| SCHEMBL14077694 | 0.75 | SLC16A1 (0.57) | SLC16A1CYP2C9CYP3A4SLC16A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021217111-A1 | PH RESPONSIVE BLOCK COPOLYMER COMPOSITIONS AND MICELLES THAT INHIBIT MCT 1 AND RELATED PROTEINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-10-28 | — | — | WO | disclosed |